Electromed (NYSE:ELMD) reported Q2 EPS of $0.11, $0.09 better than the analyst estimate of $0.02. Revenue for the quarter came in at $11.7 million versus the consensus estimate of $11.05 million.
Electromed (NYSE:ELMD) reported Q2 EPS of $0.11, $0.09 better than the analyst estimate of $0.02. Revenue for the quarter came in at $11.7 million versus the consensus estimate of $11.05 million.